Proactiveinvestors USA & Canada VolitionRx https://www.proactiveinvestors.com Proactiveinvestors USA & Canada VolitionRx RSS feed en Wed, 13 Nov 2019 08:36:44 -0500 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) VolitionRx records first revenues from research kits and strengthens balance sheet in third quarter https://www.proactiveinvestors.com/companies/news/906968/volitionrx-records-first-revenues-from-research-kits-and-strengthens-balance-sheet-in-third-quarter-906968.html Wed, 13 Nov 2019 13:07:00 -0500 https://www.proactiveinvestors.com/companies/news/906968/volitionrx-records-first-revenues-from-research-kits-and-strengthens-balance-sheet-in-third-quarter-906968.html VolitionRx gets $500,000 loan to continue build-up of veterinary medicine subsidiary https://www.proactiveinvestors.com/companies/news/905844/volitionrx-gets-500000-loan-to-continue-build-up-of-veterinary-medicine-subsidiary-905844.html Tue, 29 Oct 2019 13:56:00 -0400 https://www.proactiveinvestors.com/companies/news/905844/volitionrx-gets-500000-loan-to-continue-build-up-of-veterinary-medicine-subsidiary-905844.html VolitionRx's veterinary subsidiary wins 12.5% equity stake from Texas A&M https://www.proactiveinvestors.com/companies/news/905678/volitionrx-s-veterinary-subsidiary-wins-125-equity-stake-from-texas-am-905678.html Fri, 25 Oct 2019 17:30:00 -0400 https://www.proactiveinvestors.com/companies/news/905678/volitionrx-s-veterinary-subsidiary-wins-125-equity-stake-from-texas-am-905678.html VolitionRx’s Nu.Q cancer-screening blood tests could replace colonoscopies, biopsies https://www.proactiveinvestors.com/companies/news/222612/volitionrxs-nuq-cancer-screening-blood-tests-could-replace-colonoscopies-biopsies-222612.html Tue, 22 Oct 2019 11:00:00 -0400 https://www.proactiveinvestors.com/companies/news/222612/volitionrxs-nuq-cancer-screening-blood-tests-could-replace-colonoscopies-biopsies-222612.html VolitionRX's Nu.Q platform to be touted at major veterinary conference in Houston https://www.proactiveinvestors.com/companies/news/905158/volitionrx-s-nuq-platform-to-be-touted-at-major-veterinary-conference-in-houston-905158.html Fri, 18 Oct 2019 13:46:00 -0400 https://www.proactiveinvestors.com/companies/news/905158/volitionrx-s-nuq-platform-to-be-touted-at-major-veterinary-conference-in-houston-905158.html VolitionRx achieves 'massive breakthrough' in its Nu.Q Capture cancer diagnostic technology https://www.proactiveinvestors.com/companies/news/902986/volitionrx-achieves--massive-breakthrough--in-its-nuq-capture-cancer-diagnostic-technology-902986.html Wed, 18 Sep 2019 16:58:00 -0400 https://www.proactiveinvestors.com/companies/news/902986/volitionrx-achieves--massive-breakthrough--in-its-nuq-capture-cancer-diagnostic-technology-902986.html VolitionRx hits milestone in Nu.Q Capture blood-based cancer-detection technology https://www.proactiveinvestors.com/companies/news/902877/volitionrx-hits-milestone-in-nuq-capture-blood-based-cancer-detection-technology-902877.html Tue, 17 Sep 2019 20:19:00 -0400 https://www.proactiveinvestors.com/companies/news/902877/volitionrx-hits-milestone-in-nuq-capture-blood-based-cancer-detection-technology-902877.html VolitionRx reports strong second quarter as it moves forward on key MoUs https://www.proactiveinvestors.com/companies/news/900664/volitionrx-reports-strong-second-quarter-as-it-moves-forward-on-key-mous-900664.html Tue, 13 Aug 2019 14:07:00 -0400 https://www.proactiveinvestors.com/companies/news/900664/volitionrx-reports-strong-second-quarter-as-it-moves-forward-on-key-mous-900664.html VolitionRx balance sheet strengthens in second quarter with cash increasing significantly https://www.proactiveinvestors.com/companies/news/900566/volitionrx-balance-sheet-strengthens-in-second-quarter-with-cash-increasing-significantly-900566.html Mon, 12 Aug 2019 20:35:00 -0400 https://www.proactiveinvestors.com/companies/news/900566/volitionrx-balance-sheet-strengthens-in-second-quarter-with-cash-increasing-significantly-900566.html VolitionRx forms new Texas veterinary subsidiary, taps animal health expert Nathan Dewsbury to head it https://www.proactiveinvestors.com/companies/news/900392/volitionrx-forms-new-texas-veterinary-subsidiary-taps-animal-health-expert-nathan-dewsbury-to-head-it-900392.html Thu, 08 Aug 2019 15:00:00 -0400 https://www.proactiveinvestors.com/companies/news/900392/volitionrx-forms-new-texas-veterinary-subsidiary-taps-animal-health-expert-nathan-dewsbury-to-head-it-900392.html VolitionRX brings its Nu.Q cancer-screening platform to China https://www.proactiveinvestors.com/companies/news/224160/volitionrx-brings-its-nuq-cancer-screening-platform-to-china-224160.html Thu, 18 Jul 2019 15:15:00 -0400 https://www.proactiveinvestors.com/companies/news/224160/volitionrx-brings-its-nuq-cancer-screening-platform-to-china-224160.html VolitionRx Limited awarded an additional $1.4 million in non-dilutive funding https://www.proactiveinvestors.com/companies/news/223687/volitionrx-limited-awarded-an-additional-14-million-in-non-dilutive-funding-223687.html Wed, 10 Jul 2019 13:32:00 -0400 https://www.proactiveinvestors.com/companies/news/223687/volitionrx-limited-awarded-an-additional-14-million-in-non-dilutive-funding-223687.html VolitionRx well positioned as it enters Q2 after strengthening balance sheet https://www.proactiveinvestors.com/companies/news/313277/volitionrx-well-positioned-as-it-enters-q2-after-strengthening-balance-sheet-13277.html Thu, 09 May 2019 12:17:00 -0400 https://www.proactiveinvestors.com/companies/news/313277/volitionrx-well-positioned-as-it-enters-q2-after-strengthening-balance-sheet-13277.html VolitionRx boosts cash reserves in 1Q https://www.proactiveinvestors.com/companies/news/219919/volitionrx-boosts-cash-reserves-in-1q-219919.html Wed, 08 May 2019 20:33:00 -0400 https://www.proactiveinvestors.com/companies/news/219919/volitionrx-boosts-cash-reserves-in-1q-219919.html VolitionRx updates investors on Nu.Q technology progress, new paths to revenue at NYSE event https://www.proactiveinvestors.com/companies/news/218322/volitionrx-updates-investors-on-nuq-technology-progress-new-paths-to-revenue-at-nyse-event-218322.html Wed, 10 Apr 2019 12:45:00 -0400 https://www.proactiveinvestors.com/companies/news/218322/volitionrx-updates-investors-on-nuq-technology-progress-new-paths-to-revenue-at-nyse-event-218322.html VolitionRX hosts Capital Markets Day at the NYSE https://www.proactiveinvestors.com/companies/news/312934/volitionrx-hosts-capital-markets-day-at-the-nyse-12934.html Tue, 09 Apr 2019 16:14:00 -0400 https://www.proactiveinvestors.com/companies/news/312934/volitionrx-hosts-capital-markets-day-at-the-nyse-12934.html VolitionRx subsidiary inks pact with Texas A&M University to develop Nu.Q veterinary diagnostic blood tests https://www.proactiveinvestors.com/companies/news/218248/volitionrx-subsidiary-inks-pact-with-texas-am-university-to-develop-nuq-veterinary-diagnostic-blood-tests-218248.html Tue, 09 Apr 2019 15:31:00 -0400 https://www.proactiveinvestors.com/companies/news/218248/volitionrx-subsidiary-inks-pact-with-texas-am-university-to-develop-nuq-veterinary-diagnostic-blood-tests-218248.html VolitionRx expands its lung cancer detection clinical trial program using its novel Nu.Q blood test https://www.proactiveinvestors.com/companies/news/217886/volitionrx-expands-its-lung-cancer-detection-clinical-trial-program-using-its-novel-nuq-blood-test-217886.html Wed, 03 Apr 2019 14:34:00 -0400 https://www.proactiveinvestors.com/companies/news/217886/volitionrx-expands-its-lung-cancer-detection-clinical-trial-program-using-its-novel-nuq-blood-test-217886.html VolitionRx well funded as it advances development of its novel cancer tests https://www.proactiveinvestors.com/companies/news/312599/volitionrx-well-funded-as-it-advances-development-of-its-novel-cancer-tests-12599.html Thu, 14 Mar 2019 15:02:00 -0400 https://www.proactiveinvestors.com/companies/news/312599/volitionrx-well-funded-as-it-advances-development-of-its-novel-cancer-tests-12599.html VolitionRx strengthens balance sheet in 2018 as Nu.Q blood test notches further advances in cancer-detection trials https://www.proactiveinvestors.com/companies/news/216482/volitionrx-strengthens-balance-sheet-in-2018-as-nuq-blood-test-notches-further-advances-in-cancer-detection-trials-216482.html Thu, 14 Mar 2019 12:50:00 -0400 https://www.proactiveinvestors.com/companies/news/216482/volitionrx-strengthens-balance-sheet-in-2018-as-nuq-blood-test-notches-further-advances-in-cancer-detection-trials-216482.html Growth 'guaranteed' for a well funded Volition Rx https://www.proactiveinvestors.com/companies/news/311135/growth-guaranteed-for-a-well-funded-volition-rx-11135.html Thu, 08 Nov 2018 09:01:00 -0500 https://www.proactiveinvestors.com/companies/news/311135/growth-guaranteed-for-a-well-funded-volition-rx-11135.html VolitionRx reports several highlights in 2018 and eyes key milestones going into 2019 https://www.proactiveinvestors.com/companies/news/208777/volitionrx-reports-several-highlights-in-2018-and-eyes-key-milestones-going-into-2019-208777.html Wed, 07 Nov 2018 21:53:00 -0500 https://www.proactiveinvestors.com/companies/news/208777/volitionrx-reports-several-highlights-in-2018-and-eyes-key-milestones-going-into-2019-208777.html VolitionRx's revolutionary Nu.Q blood tests could change the future of cancer screening https://www.proactiveinvestors.com/companies/news/207876/volitionrx-s-revolutionary-nuq-blood-tests-could-change-the-future-of-cancer-screening-207876.html Thu, 25 Oct 2018 17:30:00 -0400 https://www.proactiveinvestors.com/companies/news/207876/volitionrx-s-revolutionary-nuq-blood-tests-could-change-the-future-of-cancer-screening-207876.html VolitionRx moves into veterinary medicine after encouraging study results https://www.proactiveinvestors.com/companies/news/206405/volitionrx-moves-into-veterinary-medicine-after-encouraging-study-results-206405.html Thu, 04 Oct 2018 13:50:00 -0400 https://www.proactiveinvestors.com/companies/news/206405/volitionrx-moves-into-veterinary-medicine-after-encouraging-study-results-206405.html VolitionRx releases prostate cancer data, moving towards larger trials https://www.proactiveinvestors.com/companies/news/310718/volitionrx-releases-prostate-cancer-data-moving-towards-larger-trials-10718.html Wed, 03 Oct 2018 12:50:00 -0400 https://www.proactiveinvestors.com/companies/news/310718/volitionrx-releases-prostate-cancer-data-moving-towards-larger-trials-10718.html VolitionRx's Nu.Q blood-based diagnostic tests offer great potential, says Oppenheimer analyst https://www.proactiveinvestors.com/companies/news/202970/volitionrx-s-nuq-blood-based-diagnostic-tests-offer-great-potential-says-oppenheimer-analyst-202970.html Wed, 15 Aug 2018 13:35:00 -0400 https://www.proactiveinvestors.com/companies/news/202970/volitionrx-s-nuq-blood-based-diagnostic-tests-offer-great-potential-says-oppenheimer-analyst-202970.html VolitionRx 'has a lot of shots on goal' as development of assays advances https://www.proactiveinvestors.com/companies/news/310114/volitionrx-has-a-lot-of-shots-on-goal-as-development-of-assays-advances-10114.html Tue, 14 Aug 2018 13:00:00 -0400 https://www.proactiveinvestors.com/companies/news/310114/volitionrx-has-a-lot-of-shots-on-goal-as-development-of-assays-advances-10114.html VolitionRx expects its Nu.Q blood-based test kits to generate new revenue in coming quarter https://www.proactiveinvestors.com/companies/news/202793/volitionrx-expects-its-nuq-blood-based-test-kits-to-generate-new-revenue-in-coming-quarter-202793.html Mon, 13 Aug 2018 21:15:00 -0400 https://www.proactiveinvestors.com/companies/news/202793/volitionrx-expects-its-nuq-blood-based-test-kits-to-generate-new-revenue-in-coming-quarter-202793.html VolitionRx unveils data showing its Nu.Q assays detect aggressive prostate cancer in men with 94% accuracy https://www.proactiveinvestors.com/companies/news/202777/volitionrx-unveils-data-showing-its-nuq-assays-detect-aggressive-prostate-cancer-in-men-with-94-accuracy-202777.html Mon, 13 Aug 2018 15:08:00 -0400 https://www.proactiveinvestors.com/companies/news/202777/volitionrx-unveils-data-showing-its-nuq-assays-detect-aggressive-prostate-cancer-in-men-with-94-accuracy-202777.html VolitionRx completes blood sample collection as part of joint University of Oxford endometriosis study https://www.proactiveinvestors.com/companies/news/202595/volitionrx-completes-blood-sample-collection-as-part-of-joint-university-of-oxford-endometriosis-study-202595.html Thu, 09 Aug 2018 13:42:00 -0400 https://www.proactiveinvestors.com/companies/news/202595/volitionrx-completes-blood-sample-collection-as-part-of-joint-university-of-oxford-endometriosis-study-202595.html VolitionRx enters into US$9mln private placement https://www.proactiveinvestors.com/companies/news/202484/volitionrx-enters-into-us9mln-private-placement-202484.html Wed, 08 Aug 2018 11:45:00 -0400 https://www.proactiveinvestors.com/companies/news/202484/volitionrx-enters-into-us9mln-private-placement-202484.html VolitionRx's market in cancer detection expanding sharply with its Nu.Q product, says Maxim https://www.proactiveinvestors.com/companies/news/202041/volitionrx-s-market-in-cancer-detection-expanding-sharply-with-its-nuq-product-says-maxim-202041.html Wed, 01 Aug 2018 19:38:00 -0400 https://www.proactiveinvestors.com/companies/news/202041/volitionrx-s-market-in-cancer-detection-expanding-sharply-with-its-nuq-product-says-maxim-202041.html VolitionRx releases disease detection research kit to expand global product range https://www.proactiveinvestors.com/companies/news/202022/volitionrx-releases-disease-detection-research-kit-to-expand-global-product-range-202022.html Wed, 01 Aug 2018 14:45:00 -0400 https://www.proactiveinvestors.com/companies/news/202022/volitionrx-releases-disease-detection-research-kit-to-expand-global-product-range-202022.html VolitionRx unveils three colorectal cancer detection studies in Asia https://www.proactiveinvestors.com/companies/news/200496/volitionrx-unveils-three-colorectal-cancer-detection-studies-in-asia-200496.html Tue, 10 Jul 2018 18:00:00 -0400 https://www.proactiveinvestors.com/companies/news/200496/volitionrx-unveils-three-colorectal-cancer-detection-studies-in-asia-200496.html VolitionRx secures US$700,000 in funding to continue developing cancer diagnostic tests https://www.proactiveinvestors.com/companies/news/199965/volitionrx-secures-us700000-in-funding-to-continue-developing-cancer-diagnostic-tests-199965.html Mon, 02 Jul 2018 17:23:00 -0400 https://www.proactiveinvestors.com/companies/news/199965/volitionrx-secures-us700000-in-funding-to-continue-developing-cancer-diagnostic-tests-199965.html VolitionRx price target is kept at $7 by Wall Street research house SeeThru Equity https://www.proactiveinvestors.com/companies/news/198210/volitionrx-price-target-is-kept-at-7-by-wall-street-research-house-seethru-equity-198210.html Mon, 04 Jun 2018 16:23:00 -0400 https://www.proactiveinvestors.com/companies/news/198210/volitionrx-price-target-is-kept-at-7-by-wall-street-research-house-seethru-equity-198210.html VolitionRx initiated with US$7 price target and Outperform rating by Oppenheimer https://www.proactiveinvestors.com/companies/news/197574/volitionrx-initiated-with-us7-price-target-and-outperform-rating-by-oppenheimer-197574.html Wed, 23 May 2018 15:53:00 -0400 https://www.proactiveinvestors.com/companies/news/197574/volitionrx-initiated-with-us7-price-target-and-outperform-rating-by-oppenheimer-197574.html VolitionRx to take part in Bank of America Merrill Lynch's 2018 Health Care Conference https://www.proactiveinvestors.com/companies/news/196937/volitionrx-to-take-part-in-bank-of-america-merrill-lynch-s-2018-health-care-conference-196937.html Mon, 14 May 2018 14:06:00 -0400 https://www.proactiveinvestors.com/companies/news/196937/volitionrx-to-take-part-in-bank-of-america-merrill-lynch-s-2018-health-care-conference-196937.html Q1 'very much a building quarter' for VolitionRx with growing cash reserves https://www.proactiveinvestors.com/companies/news/309274/q1-very-much-a-building-quarter-for-volitionrx-with-growing-cash-reserves-9274.html Fri, 11 May 2018 13:16:00 -0400 https://www.proactiveinvestors.com/companies/news/309274/q1-very-much-a-building-quarter-for-volitionrx-with-growing-cash-reserves-9274.html VolitionRx boosts cash reserves in 1Q, inks distribution deal with Active Motif https://www.proactiveinvestors.com/companies/news/196780/volitionrx-boosts-cash-reserves-in-1q-inks-distribution-deal-with-active-motif-196780.html Thu, 10 May 2018 20:50:00 -0400 https://www.proactiveinvestors.com/companies/news/196780/volitionrx-boosts-cash-reserves-in-1q-inks-distribution-deal-with-active-motif-196780.html VolitionRx signs distribution agreement with Active Motif to sell research-use-only kits https://www.proactiveinvestors.com/companies/news/196662/volitionrx-signs-distribution-agreement-with-active-motif-to-sell-research-use-only-kits-196662.html Wed, 09 May 2018 14:20:00 -0400 https://www.proactiveinvestors.com/companies/news/196662/volitionrx-signs-distribution-agreement-with-active-motif-to-sell-research-use-only-kits-196662.html VolitionRx price target raised to US$7 by microcap research house on high hopes for Nu.Q cancer screen https://www.proactiveinvestors.com/companies/news/193492/volitionrx-price-target-raised-to-us7-by-microcap-research-house-on-high-hopes-for-nuq-cancer-screen-193492.html Tue, 20 Mar 2018 16:26:00 -0400 https://www.proactiveinvestors.com/companies/news/193492/volitionrx-price-target-raised-to-us7-by-microcap-research-house-on-high-hopes-for-nuq-cancer-screen-193492.html VolitionRx closes offering, raises US$8.4mln https://www.proactiveinvestors.com/companies/news/193107/volitionrx-closes-offering-raises-us84mln-193107.html Tue, 13 Mar 2018 20:30:00 -0400 https://www.proactiveinvestors.com/companies/news/193107/volitionrx-closes-offering-raises-us84mln-193107.html VolitionRX prices stock offering at US$2.40 a share https://www.proactiveinvestors.com/companies/news/192930/VolitionRX-prices-stock-offering-at-US-2.40-a-share-192930.html Fri, 09 Mar 2018 14:44:00 -0500 https://www.proactiveinvestors.com/companies/news/192930/VolitionRX-prices-stock-offering-at-US-2.40-a-share-192930.html VolitionRx bolsters scientific advisory board with Harvard professor https://www.proactiveinvestors.com/companies/news/192772/volitionrx-bolsters-scientific-advisory-board-with-harvard-professor-192772.html Wed, 07 Mar 2018 19:50:00 -0500 https://www.proactiveinvestors.com/companies/news/192772/volitionrx-bolsters-scientific-advisory-board-with-harvard-professor-192772.html VolitionRX boss praises “strong progress” in 2017; thinks Nu.QTM panel could be new gold standard in cancer detection https://www.proactiveinvestors.com/companies/news/192527/volitionrx-boss-praises-strong-progress-in-2017-thinks-nuqtm-panel-could-be-new-gold-standard-in-cancer-detection-192527.html Fri, 02 Mar 2018 13:16:00 -0500 https://www.proactiveinvestors.com/companies/news/192527/volitionrx-boss-praises-strong-progress-in-2017-thinks-nuqtm-panel-could-be-new-gold-standard-in-cancer-detection-192527.html VolitionRx reports positive interim results from Danish colorectal cancer study https://www.proactiveinvestors.com/companies/news/308833/volitionrx-reports-positive-interim-results-from-danish-colorectal-cancer-study-8833.html Fri, 02 Mar 2018 11:27:00 -0500 https://www.proactiveinvestors.com/companies/news/308833/volitionrx-reports-positive-interim-results-from-danish-colorectal-cancer-study-8833.html VolitionRx hails interim results of Danish trial for screening colorectal cancer https://www.proactiveinvestors.com/companies/news/192279/volitionrx-hails-interim-results-of-danish-trial-for-screening-colorectal-cancer-192279.html Tue, 27 Feb 2018 15:30:00 -0500 https://www.proactiveinvestors.com/companies/news/192279/volitionrx-hails-interim-results-of-danish-trial-for-screening-colorectal-cancer-192279.html VolitionRx hails successful conclusion of Danish logistics study https://www.proactiveinvestors.com/companies/news/191172/volitionrx-hails-successful-conclusion-of-danish-logistics-study-191172.html Mon, 05 Feb 2018 19:41:00 -0500 https://www.proactiveinvestors.com/companies/news/191172/volitionrx-hails-successful-conclusion-of-danish-logistics-study-191172.html VolitionRx results from huge cancer test trial due; HC Wainwright upbeat https://www.proactiveinvestors.com/companies/news/190778/volitionrx-results-from-huge-cancer-test-trial-due-hc-wainwright-upbeat-190778.html Mon, 29 Jan 2018 20:18:00 -0500 https://www.proactiveinvestors.com/companies/news/190778/volitionrx-results-from-huge-cancer-test-trial-due-hc-wainwright-upbeat-190778.html Cancer Diagnostics group VolitionRX looks ahead to 2018 https://www.proactiveinvestors.com/companies/news/308583/cancer-diagnostics-group-volitionrx-looks-ahead-to-2018-8583.html Thu, 04 Jan 2018 10:02:00 -0500 https://www.proactiveinvestors.com/companies/news/308583/cancer-diagnostics-group-volitionrx-looks-ahead-to-2018-8583.html VolitionRx eyeing 'breakthrough' 2018 as it completes Copenhagen trial https://www.proactiveinvestors.com/companies/news/189469/volitionrx-eyeing-breakthrough-2018-as-it-completes-copenhagen-trial-189469.html Wed, 03 Jan 2018 18:33:00 -0500 https://www.proactiveinvestors.com/companies/news/189469/volitionrx-eyeing-breakthrough-2018-as-it-completes-copenhagen-trial-189469.html VolitionRx surges after unveiling plans to conduct two massive clinical studies https://www.proactiveinvestors.com/companies/news/187101/volitionrx-surges-after-unveiling-plans-to-conduct-two-massive-clinical-studies-187101.html Fri, 10 Nov 2017 15:47:00 -0500 https://www.proactiveinvestors.com/companies/news/187101/volitionrx-surges-after-unveiling-plans-to-conduct-two-massive-clinical-studies-187101.html VolitionRx signs MoU with National Taiwan University for two large clinical studies https://www.proactiveinvestors.com/companies/news/308355/volitionrx-signs-mou-with-national-taiwan-university-for-two-large-clinical-studies-8355.html Fri, 10 Nov 2017 15:00:00 -0500 https://www.proactiveinvestors.com/companies/news/308355/volitionrx-signs-mou-with-national-taiwan-university-for-two-large-clinical-studies-8355.html VolitionRx first revenue from Nu Q technology is major milestone https://www.proactiveinvestors.com/companies/news/184546/volitionrx-first-revenue-from-nu-q-technology-is-major-milestone-184546.html Tue, 26 Sep 2017 14:26:00 -0400 https://www.proactiveinvestors.com/companies/news/184546/volitionrx-first-revenue-from-nu-q-technology-is-major-milestone-184546.html VolitionRx lifted by cash infusion and first order for new range of "research use only" kits https://www.proactiveinvestors.com/companies/news/184453/volitionrx-lifted-by-cash-infusion-and-first-order-for-new-range-of-research-use-only-kits-184453.html Fri, 22 Sep 2017 14:23:00 -0400 https://www.proactiveinvestors.com/companies/news/184453/volitionrx-lifted-by-cash-infusion-and-first-order-for-new-range-of-research-use-only-kits-184453.html VolitionRx eyeing launch of colorectal test in Europe in 2018 https://www.proactiveinvestors.com/companies/news/184249/volitionrx-eyeing-launch-of-colorectal-test-in-europe-in-2018-184249.html Tue, 19 Sep 2017 21:00:00 -0400 https://www.proactiveinvestors.com/companies/news/184249/volitionrx-eyeing-launch-of-colorectal-test-in-europe-in-2018-184249.html VolitionRx Ltd granted four new patents https://www.proactiveinvestors.com/companies/news/184024/volitionrx-ltd-granted-four-new-patents-184024.html Thu, 14 Sep 2017 20:52:00 -0400 https://www.proactiveinvestors.com/companies/news/184024/volitionrx-ltd-granted-four-new-patents-184024.html VolitionRx to work with world-renowned professor to secure large trials in a range of cancers https://www.proactiveinvestors.com/companies/news/182872/volitionrx-to-work-with-world-renowned-professor-to-secure-large-trials-in-a-range-of-cancers-182872.html Wed, 23 Aug 2017 14:01:00 -0400 https://www.proactiveinvestors.com/companies/news/182872/volitionrx-to-work-with-world-renowned-professor-to-secure-large-trials-in-a-range-of-cancers-182872.html VolitionRx targeting several milestones in second half of 2017 https://www.proactiveinvestors.com/companies/news/182279/volitionrx-targeting-several-milestones-in-second-half-of-2017-182279.html Thu, 10 Aug 2017 15:08:00 -0400 https://www.proactiveinvestors.com/companies/news/182279/volitionrx-targeting-several-milestones-in-second-half-of-2017-182279.html VolitionRx continuing to make strong progress with another 'very, very good quarter' https://www.proactiveinvestors.com/companies/news/307916/volitionrx-continuing-to-make-strong-progress-with-another-very-very-good-quarter--7916.html Thu, 10 Aug 2017 14:00:00 -0400 https://www.proactiveinvestors.com/companies/news/307916/volitionrx-continuing-to-make-strong-progress-with-another-very-very-good-quarter--7916.html Cancer test group VolitionRx's US trial is huge result, says chief executive https://www.proactiveinvestors.com/companies/news/181518/cancer-test-group-volitionrx-s-us-trial-is-huge-result-says-chief-executive-181518.html Mon, 31 Jul 2017 14:55:00 -0400 https://www.proactiveinvestors.com/companies/news/181518/cancer-test-group-volitionrx-s-us-trial-is-huge-result-says-chief-executive-181518.html VolitionRx Limited's large US clinical study is a major milestone https://www.proactiveinvestors.com/companies/news/181087/volitionrx-limited-s-large-us-clinical-study-is-a-major-milestone-181087.html Tue, 18 Jul 2017 19:29:00 -0400 https://www.proactiveinvestors.com/companies/news/181087/volitionrx-limited-s-large-us-clinical-study-is-a-major-milestone-181087.html 'About as big as it gets' - VolitionRx's Cameron Reynolds on their US colorectal screening trial https://www.proactiveinvestors.com/companies/news/307805/-about-as-big-as-it-gets-volitionrx-s-cameron-reynolds-on-their-us-colorectal-screening-trial-7805.html Tue, 18 Jul 2017 12:25:00 -0400 https://www.proactiveinvestors.com/companies/news/307805/-about-as-big-as-it-gets-volitionrx-s-cameron-reynolds-on-their-us-colorectal-screening-trial-7805.html VolitionRx to present at two Barcelona conferences https://www.proactiveinvestors.com/companies/news/180163/volitionrx-to-present-at-two-barcelona-conferences-180163.html Fri, 30 Jun 2017 18:51:00 -0400 https://www.proactiveinvestors.com/companies/news/180163/volitionrx-to-present-at-two-barcelona-conferences-180163.html VolitionRx corrects May statement on triage test https://www.proactiveinvestors.com/companies/news/179924/volitionrx-corrects-may-statement-on-triage-test-179924.html Tue, 27 Jun 2017 16:23:00 -0400 https://www.proactiveinvestors.com/companies/news/179924/volitionrx-corrects-may-statement-on-triage-test-179924.html VolitionRX spreading the word to investors in June https://www.proactiveinvestors.com/companies/news/178395/volitionrx-spreading-the-word-to-investors-in-june-178395.html Fri, 26 May 2017 12:57:00 -0400 https://www.proactiveinvestors.com/companies/news/178395/volitionrx-spreading-the-word-to-investors-in-june-178395.html VolitionRx pilot study published for peer review https://www.proactiveinvestors.com/companies/news/178012/volitionrx-pilot-study-published-for-peer-review-178012.html Thu, 18 May 2017 14:31:00 -0400 https://www.proactiveinvestors.com/companies/news/178012/volitionrx-pilot-study-published-for-peer-review-178012.html VolitionRX off to strong start in 2017 https://www.proactiveinvestors.com/companies/news/177662/volitionrx-off-to-strong-start-in-2017-177662.html Thu, 11 May 2017 13:16:00 -0400 https://www.proactiveinvestors.com/companies/news/177662/volitionrx-off-to-strong-start-in-2017-177662.html VolitionRx Ltd hails positive results from its Nu.Q studies https://www.proactiveinvestors.com/companies/news/177537/volitionrx-ltd-hails-positive-results-from-its-nuq-studies-177537.html Tue, 09 May 2017 17:38:00 -0400 https://www.proactiveinvestors.com/companies/news/177537/volitionrx-ltd-hails-positive-results-from-its-nuq-studies-177537.html VolitionRx commences first triage study in Asia, gets ethical approval for final phase of a study in Denmark https://www.proactiveinvestors.com/companies/news/177008/volitionrx-commences-first-triage-study-in-asia-gets-ethical-approval-for-final-phase-of-a-study-in-denmark-177008.html Thu, 27 Apr 2017 14:37:00 -0400 https://www.proactiveinvestors.com/companies/news/177008/volitionrx-commences-first-triage-study-in-asia-gets-ethical-approval-for-final-phase-of-a-study-in-denmark-177008.html VolitionRX to expedite clinical trials after opening state-of-the-art lab https://www.proactiveinvestors.com/companies/news/176741/volitionrx-to-expedite-clinical-trials-after-opening-state-of-the-art-lab-176741.html Fri, 21 Apr 2017 15:12:00 -0400 https://www.proactiveinvestors.com/companies/news/176741/volitionrx-to-expedite-clinical-trials-after-opening-state-of-the-art-lab-176741.html VolitionRx appoints new finance head https://www.proactiveinvestors.com/companies/news/176306/volitionrx-appoints-new-finance-head-176306.html Tue, 11 Apr 2017 13:39:00 -0400 https://www.proactiveinvestors.com/companies/news/176306/volitionrx-appoints-new-finance-head-176306.html VolitionRX appoints high profile cancer consultant to boost funding in Texas https://www.proactiveinvestors.com/companies/news/175621/volitionrx-appoints-high-profile-cancer-consultant-to-boost-funding-in-texas-175621.html Wed, 29 Mar 2017 14:37:00 -0400 https://www.proactiveinvestors.com/companies/news/175621/volitionrx-appoints-high-profile-cancer-consultant-to-boost-funding-in-texas-175621.html VolitionRx to ring Wall St Closing Bell Monday https://www.proactiveinvestors.com/companies/news/174712/volitionrx-to-ring-wall-st-closing-bell-monday-174712.html Mon, 13 Mar 2017 18:15:00 -0400 https://www.proactiveinvestors.com/companies/news/174712/volitionrx-to-ring-wall-st-closing-bell-monday-174712.html Broker Rodman upbeat on VolitionRx's NuQ blood test launch https://www.proactiveinvestors.com/companies/news/174705/broker-rodman-upbeat-on-volitionrx-s-nuq-blood-test-launch-174705.html Mon, 13 Mar 2017 14:09:00 -0400 https://www.proactiveinvestors.com/companies/news/174705/broker-rodman-upbeat-on-volitionrx-s-nuq-blood-test-launch-174705.html VolitionRx looks forward to another year of continued success https://www.proactiveinvestors.com/companies/news/174626/volitionrx-looks-forward-to-another-year-of-continued-success-174626.html Fri, 10 Mar 2017 15:08:00 -0500 https://www.proactiveinvestors.com/companies/news/174626/volitionrx-looks-forward-to-another-year-of-continued-success-174626.html VolitionRx chief hails "wonderful" progress accomplished in 2016 https://www.proactiveinvestors.com/companies/news/307080/volitionrx-chief-hails-wonderful-progress-accomplished-in-2016-7080.html Fri, 10 Mar 2017 14:28:00 -0500 https://www.proactiveinvestors.com/companies/news/307080/volitionrx-chief-hails-wonderful-progress-accomplished-in-2016-7080.html VolitionRx to present at the 29th annual ROTH Conference https://www.proactiveinvestors.com/companies/news/174490/volitionrx-to-present-at-the-29th-annual-roth-conference-174490.html Wed, 08 Mar 2017 20:15:00 -0500 https://www.proactiveinvestors.com/companies/news/174490/volitionrx-to-present-at-the-29th-annual-roth-conference-174490.html VolitionRX kicks off Nu.Q colorectal cancer screening test in Denmark https://www.proactiveinvestors.com/companies/news/174139/volitionrx-kicks-off-nuq-colorectal-cancer-screening-test-in-denmark-174139.html Thu, 02 Mar 2017 14:04:00 -0500 https://www.proactiveinvestors.com/companies/news/174139/volitionrx-kicks-off-nuq-colorectal-cancer-screening-test-in-denmark-174139.html VolitionRx Limited's triage test results validated in prospective trial https://www.proactiveinvestors.com/companies/news/173745/volitionrx-limited-s-triage-test-results-validated-in-prospective-trial-173745.html Fri, 24 Feb 2017 21:17:00 -0500 https://www.proactiveinvestors.com/companies/news/173745/volitionrx-limited-s-triage-test-results-validated-in-prospective-trial-173745.html VolitionRx to attend BTIG 2017 MedTech Conference https://www.proactiveinvestors.com/companies/news/173636/volitionrx-to-attend-btig-2017-medtech-conference-173636.html Thu, 23 Feb 2017 20:07:00 -0500 https://www.proactiveinvestors.com/companies/news/173636/volitionrx-to-attend-btig-2017-medtech-conference-173636.html VolitionRx to present at 2nd Annual Disruptive Growth & Healthcare Conference https://www.proactiveinvestors.com/companies/news/172940/volitionrx-to-present-at-2nd-annual-disruptive-growth-healthcare-conference-172940.html Thu, 09 Feb 2017 18:48:00 -0500 https://www.proactiveinvestors.com/companies/news/172940/volitionrx-to-present-at-2nd-annual-disruptive-growth-healthcare-conference-172940.html VolitionRx eyes new markets with appointment of Asian VP https://www.proactiveinvestors.com/companies/news/171215/volitionrx-eyes-new-markets-with-appointment-of-asian-vp-171215.html Thu, 05 Jan 2017 13:40:00 -0500 https://www.proactiveinvestors.com/companies/news/171215/volitionrx-eyes-new-markets-with-appointment-of-asian-vp-171215.html VolitionRx cancer diagnostic test achieves CE Marking, preps for Europe launch https://www.proactiveinvestors.com/companies/news/171105/volitionrx-cancer-diagnostic-test-achieves-ce-marking-preps-for-europe-launch-171105.html Tue, 03 Jan 2017 18:36:00 -0500 https://www.proactiveinvestors.com/companies/news/171105/volitionrx-cancer-diagnostic-test-achieves-ce-marking-preps-for-europe-launch-171105.html VolitionRx chief hails importance of colorectal cancer screening test CE mark https://www.proactiveinvestors.com/companies/news/306670/volitionrx-chief-hails-importance-of-colorectal-cancer-screening-test-ce-mark-6670.html Tue, 03 Jan 2017 14:10:00 -0500 https://www.proactiveinvestors.com/companies/news/306670/volitionrx-chief-hails-importance-of-colorectal-cancer-screening-test-ce-mark-6670.html VolitionRx to present at 9th annual Biotech Showcase Conference https://www.proactiveinvestors.com/companies/news/170987/volitionrx-to-present-at-9th-annual-biotech-showcase-conference-170987.html Wed, 28 Dec 2016 19:23:00 -0500 https://www.proactiveinvestors.com/companies/news/170987/volitionrx-to-present-at-9th-annual-biotech-showcase-conference-170987.html VolitionRx Limited to attend Citi 2016 Global Healthcare Conference https://www.proactiveinvestors.com/companies/news/169847/volitionrx-limited-to-attend-citi-2016-global-healthcare-conference-169847.html Thu, 01 Dec 2016 19:36:00 -0500 https://www.proactiveinvestors.com/companies/news/169847/volitionrx-limited-to-attend-citi-2016-global-healthcare-conference-169847.html VolitionRx to present at Canaccord Genuity MedTech event https://www.proactiveinvestors.com/companies/news/168879/volitionrx-to-present-at-canaccord-genuity-medtech-event-168879.html Fri, 11 Nov 2016 20:11:00 -0500 https://www.proactiveinvestors.com/companies/news/168879/volitionrx-to-present-at-canaccord-genuity-medtech-event-168879.html VolitionRx eyeing launch in Europe of colorectal cancer test next year https://www.proactiveinvestors.com/companies/news/168820/volitionrx-eyeing-launch-in-europe-of-colorectal-cancer-test-next-year-168820.html Thu, 10 Nov 2016 15:10:00 -0500 https://www.proactiveinvestors.com/companies/news/168820/volitionrx-eyeing-launch-in-europe-of-colorectal-cancer-test-next-year-168820.html VolitionRx to undertake huge new blood test study https://www.proactiveinvestors.com/companies/news/168482/volitionrx-to-undertake-huge-new-blood-test-study-168482.html Thu, 03 Nov 2016 13:19:00 -0400 https://www.proactiveinvestors.com/companies/news/168482/volitionrx-to-undertake-huge-new-blood-test-study-168482.html VolitionRx outgrows its old R&D facilities https://www.proactiveinvestors.com/companies/news/168088/volitionrx-outgrows-its-old-rd-facilities-168088.html Wed, 26 Oct 2016 12:13:00 -0400 https://www.proactiveinvestors.com/companies/news/168088/volitionrx-outgrows-its-old-rd-facilities-168088.html VolitionRx says underwriter exercises over-allotment option https://www.proactiveinvestors.com/companies/news/167787/volitionrx-says-underwriter-exercises-over-allotment-option-167787.html Fri, 21 Oct 2016 19:20:00 -0400 https://www.proactiveinvestors.com/companies/news/167787/volitionrx-says-underwriter-exercises-over-allotment-option-167787.html VolitionRx says test can slash colorectal cancer 'false positives' https://www.proactiveinvestors.com/companies/news/167236/volitionrx-says-test-can-slash-colorectal-cancer-false-positives--167236.html Tue, 11 Oct 2016 14:21:00 -0400 https://www.proactiveinvestors.com/companies/news/167236/volitionrx-says-test-can-slash-colorectal-cancer-false-positives--167236.html VolitionRx Ltd set for US$10.6mln cash boost after placing https://www.proactiveinvestors.com/companies/news/167030/volitionrx-ltd-set-for-us106mln-cash-boost-after-placing-167030.html Thu, 06 Oct 2016 13:11:00 -0400 https://www.proactiveinvestors.com/companies/news/167030/volitionrx-ltd-set-for-us106mln-cash-boost-after-placing-167030.html VolitionRX prices share offer at US$5 a pop https://www.proactiveinvestors.com/companies/news/166777/volitionrx-prices-share-offer-at-us5-a-pop-166777.html Fri, 30 Sep 2016 13:04:00 -0400 https://www.proactiveinvestors.com/companies/news/166777/volitionrx-prices-share-offer-at-us5-a-pop-166777.html VolitionRx Limited colorectal cancer screening on its way https://www.proactiveinvestors.com/companies/news/305810/volitionrx-limited-colorectal-cancer-screening-on-its-way-5810.html Tue, 06 Sep 2016 13:42:00 -0400 https://www.proactiveinvestors.com/companies/news/305810/volitionrx-limited-colorectal-cancer-screening-on-its-way-5810.html VolitionRx's colorectal cancer test set to receive CE mark soon https://www.proactiveinvestors.com/companies/news/158447/volitionrx-s-colorectal-cancer-test-set-to-receive-ce-mark-soon-158447.html Tue, 06 Sep 2016 12:29:00 -0400 https://www.proactiveinvestors.com/companies/news/158447/volitionrx-s-colorectal-cancer-test-set-to-receive-ce-mark-soon-158447.html VolitionRx readies for first product launch https://www.proactiveinvestors.com/companies/news/129253/volitionrx-readies-for-first-product-launch-129253.html Thu, 11 Aug 2016 12:48:00 -0400 https://www.proactiveinvestors.com/companies/news/129253/volitionrx-readies-for-first-product-launch-129253.html VolitionRx granted fourth US patent https://www.proactiveinvestors.com/companies/news/128701/volitionrx-granted-fourth-us-patent-128701.html Wed, 27 Jul 2016 13:48:00 -0400 https://www.proactiveinvestors.com/companies/news/128701/volitionrx-granted-fourth-us-patent-128701.html VolitionRx eyes commercialisation of first cancer test https://www.proactiveinvestors.com/companies/news/128633/volitionrx-eyes-commercialisation-of-first-cancer-test-128633.html Tue, 26 Jul 2016 10:29:00 -0400 https://www.proactiveinvestors.com/companies/news/128633/volitionrx-eyes-commercialisation-of-first-cancer-test-128633.html VolitionRx appoints industry veteran to its board https://www.proactiveinvestors.com/companies/news/127491/volitionrx-appoints-industry-veteran-to-its-board-127491.html Fri, 24 Jun 2016 11:48:00 -0400 https://www.proactiveinvestors.com/companies/news/127491/volitionrx-appoints-industry-veteran-to-its-board-127491.html VolitionRX remains a buy after NuQ report, USPSTF update: Rodman & Renshaw https://www.proactiveinvestors.com/companies/news/127225/volitionrx-remains-a-buy-after-nuq-report-uspstf-update-rodman-renshaw-127225.html Thu, 16 Jun 2016 20:01:00 -0400 https://www.proactiveinvestors.com/companies/news/127225/volitionrx-remains-a-buy-after-nuq-report-uspstf-update-rodman-renshaw-127225.html VolitionRx diagnostic test validated by blood stability https://www.proactiveinvestors.com/companies/news/127115/volitionrx-diagnostic-test-validated-by-blood-stability-127115.html Tue, 14 Jun 2016 13:26:00 -0400 https://www.proactiveinvestors.com/companies/news/127115/volitionrx-diagnostic-test-validated-by-blood-stability-127115.html VolitionRx to present at two upcoming conferences https://www.proactiveinvestors.com/companies/news/126561/volitionrx-to-present-at-two-upcoming-conferences-126561.html Tue, 31 May 2016 13:48:00 -0400 https://www.proactiveinvestors.com/companies/news/126561/volitionrx-to-present-at-two-upcoming-conferences-126561.html VolitionRx handed thumbs up from SeeThruEquity analysts https://www.proactiveinvestors.com/companies/news/126282/volitionrx-handed-thumbs-up-from-seethruequity-analysts-126282.html Mon, 23 May 2016 16:53:00 -0400 https://www.proactiveinvestors.com/companies/news/126282/volitionrx-handed-thumbs-up-from-seethruequity-analysts-126282.html VolitionRX Ltd to present at colorectal cancer meeting https://www.proactiveinvestors.com/companies/news/126161/volitionrx-ltd-to-present-at-colorectal-cancer-meeting-126161.html Thu, 19 May 2016 13:30:00 -0400 https://www.proactiveinvestors.com/companies/news/126161/volitionrx-ltd-to-present-at-colorectal-cancer-meeting-126161.html VolitionRx shares rise after broker Rodman note https://www.proactiveinvestors.com/companies/news/125990/volitionrx-shares-rise-after-broker-rodman-note-125990.html Mon, 16 May 2016 19:07:00 -0400 https://www.proactiveinvestors.com/companies/news/125990/volitionrx-shares-rise-after-broker-rodman-note-125990.html VolitionRx Ltd to initiate an FDA-endorsed clinical trial of NuQ https://www.proactiveinvestors.com/companies/news/125916/volitionrx-ltd-to-initiate-an-fda-endorsed-clinical-trial-of-nuq-125916.html Fri, 13 May 2016 11:48:00 -0400 https://www.proactiveinvestors.com/companies/news/125916/volitionrx-ltd-to-initiate-an-fda-endorsed-clinical-trial-of-nuq-125916.html VolitionRx starts 'game-changing' trial for pancreatic cancer diagnosis https://www.proactiveinvestors.com/companies/news/125865/volitionrx-starts-game-changing-trial-for-pancreatic-cancer-diagnosis-125865.html Thu, 12 May 2016 12:30:00 -0400 https://www.proactiveinvestors.com/companies/news/125865/volitionrx-starts-game-changing-trial-for-pancreatic-cancer-diagnosis-125865.html VolitionRx aims for prostate test launch next year after more study success https://www.proactiveinvestors.com/companies/news/125036/volitionrx-aims-for-prostate-test-launch-next-year-after-more-study-success-125036.html Wed, 20 Apr 2016 14:21:00 -0400 https://www.proactiveinvestors.com/companies/news/125036/volitionrx-aims-for-prostate-test-launch-next-year-after-more-study-success-125036.html VolitionRx gearing up with NUQ market entry with new hire https://www.proactiveinvestors.com/companies/news/124813/volitionrx-gearing-up-with-nuq-market-entry-with-new-hire-124813.html Thu, 14 Apr 2016 13:17:00 -0400 https://www.proactiveinvestors.com/companies/news/124813/volitionrx-gearing-up-with-nuq-market-entry-with-new-hire-124813.html VolitionRx rated a 'buy' on strength of effectiveness of NuQ assays https://www.proactiveinvestors.com/companies/news/124603/volitionrx-rated-a-buy-on-strength-of-effectiveness-of-nuq-assays-124603.html Fri, 08 Apr 2016 16:20:00 -0400 https://www.proactiveinvestors.com/companies/news/124603/volitionrx-rated-a-buy-on-strength-of-effectiveness-of-nuq-assays-124603.html VolitionRx to present data from prostate cancer study https://www.proactiveinvestors.com/companies/news/124590/volitionrx-to-present-data-from-prostate-cancer-study-124590.html Fri, 08 Apr 2016 12:47:00 -0400 https://www.proactiveinvestors.com/companies/news/124590/volitionrx-to-present-data-from-prostate-cancer-study-124590.html VolitionRx Ltd delighted with European approval for two blood assays https://www.proactiveinvestors.com/companies/news/124549/volitionrx-ltd-delighted-with-european-approval-for-two-blood-assays-124549.html Thu, 07 Apr 2016 12:39:00 -0400 https://www.proactiveinvestors.com/companies/news/124549/volitionrx-ltd-delighted-with-european-approval-for-two-blood-assays-124549.html VolitionRx Limited chief “couldn’t be happier” with share offer response https://www.proactiveinvestors.com/companies/news/304818/volitionrx-limited-chief-couldnt-be-happier-with-share-offer-response-4818.html Thu, 24 Mar 2016 10:39:00 -0400 https://www.proactiveinvestors.com/companies/news/304818/volitionrx-limited-chief-couldnt-be-happier-with-share-offer-response-4818.html VolitionRx Limited raises around US$12.8mln from share offer https://www.proactiveinvestors.com/companies/news/124041/volitionrx-limited-raises-around-us128mln-from-share-offer-124041.html Wed, 23 Mar 2016 15:50:00 -0400 https://www.proactiveinvestors.com/companies/news/124041/volitionrx-limited-raises-around-us128mln-from-share-offer-124041.html VolitionRx to raise US$12.25mln at modest discount https://www.proactiveinvestors.com/companies/news/123870/volitionrx-to-raise-us1225mln-at-modest-discount-123870.html Fri, 18 Mar 2016 15:14:00 -0400 https://www.proactiveinvestors.com/companies/news/123870/volitionrx-to-raise-us1225mln-at-modest-discount-123870.html VolitionRx pleased with progress in 2015 https://www.proactiveinvestors.com/companies/news/123583/volitionrx-pleased-with-progress-in-2015-123583.html Fri, 11 Mar 2016 14:00:00 -0500 https://www.proactiveinvestors.com/companies/news/123583/volitionrx-pleased-with-progress-in-2015-123583.html VolitionRx Ltd hails findings in first non-cancer NUQ study https://www.proactiveinvestors.com/companies/news/123485/volitionrx-ltd-hails-findings-in-first-non-cancer-nuq-study-123485.html Wed, 09 Mar 2016 14:05:00 -0500 https://www.proactiveinvestors.com/companies/news/123485/volitionrx-ltd-hails-findings-in-first-non-cancer-nuq-study-123485.html VolitionRx hails 'best yet' in early colorectal cancer detection https://www.proactiveinvestors.com/companies/news/122640/volitionrx-hails-best-yet-in-early-colorectal-cancer-detection-122640.html Wed, 17 Feb 2016 16:11:00 -0500 https://www.proactiveinvestors.com/companies/news/122640/volitionrx-hails-best-yet-in-early-colorectal-cancer-detection-122640.html VolitionRx boss: trial results far better than hoped for https://www.proactiveinvestors.com/companies/news/304670/volitionrx-boss-trial-results-far-better-than-hoped-for-4670.html Wed, 17 Feb 2016 13:04:00 -0500 https://www.proactiveinvestors.com/companies/news/304670/volitionrx-boss-trial-results-far-better-than-hoped-for-4670.html VolitionRX "confident" it will launch first cancer blood-test product in Europe in 2016 https://www.proactiveinvestors.com/companies/news/304604/volitionrx-confident-it-will-launch-first-cancer-blood-test-product-in-europe-in-2016-4604.html Tue, 02 Feb 2016 16:13:00 -0500 https://www.proactiveinvestors.com/companies/news/304604/volitionrx-confident-it-will-launch-first-cancer-blood-test-product-in-europe-in-2016-4604.html VolitionRx and Surrey University to carry out prostate cancer study https://www.proactiveinvestors.com/companies/news/122055/volitionrx-and-surrey-university-to-carry-out-prostate-cancer-study-122055.html Tue, 02 Feb 2016 12:48:00 -0500 https://www.proactiveinvestors.com/companies/news/122055/volitionrx-and-surrey-university-to-carry-out-prostate-cancer-study-122055.html VolitionRx reaches key regulatory milestone for NuQ https://www.proactiveinvestors.com/companies/news/121886/volitionrx-reaches-key-regulatory-milestone-for-nuq-121886.html Thu, 28 Jan 2016 18:24:00 -0500 https://www.proactiveinvestors.com/companies/news/121886/volitionrx-reaches-key-regulatory-milestone-for-nuq-121886.html VolitionRx upbeat as major milestones loom https://www.proactiveinvestors.com/companies/news/121300/volitionrx-upbeat-as-major-milestones-loom-121300.html Wed, 13 Jan 2016 14:38:00 -0500 https://www.proactiveinvestors.com/companies/news/121300/volitionrx-upbeat-as-major-milestones-loom-121300.html VolitionRx set for catalyst-packed 2016, reckons Edison https://www.proactiveinvestors.com/companies/news/121091/volitionrx-set-for-catalyst-packed-2016-reckons-edison-121091.html Thu, 07 Jan 2016 16:39:00 -0500 https://www.proactiveinvestors.com/companies/news/121091/volitionrx-set-for-catalyst-packed-2016-reckons-edison-121091.html VolitionRx's appointment supports strategy to enter US market https://www.proactiveinvestors.com/companies/news/120980/volitionrx-s-appointment-supports-strategy-to-enter-us-market-120980.html Tue, 05 Jan 2016 16:41:00 -0500 https://www.proactiveinvestors.com/companies/news/120980/volitionrx-s-appointment-supports-strategy-to-enter-us-market-120980.html VolitionRx granted US supportive patent for core technology https://www.proactiveinvestors.com/companies/news/120937/volitionrx-granted-us-supportive-patent-for-core-technology-120937.html Mon, 04 Jan 2016 14:18:00 -0500 https://www.proactiveinvestors.com/companies/news/120937/volitionrx-granted-us-supportive-patent-for-core-technology-120937.html VolitionRx CEO: ease of use & early stage detection key with cancer blood test https://www.proactiveinvestors.com/companies/news/304454/volitionrx-ceo-ease-of-use-early-stage-detection-key-with-cancer-blood-test-4454.html Tue, 08 Dec 2015 15:36:00 -0500 https://www.proactiveinvestors.com/companies/news/304454/volitionrx-ceo-ease-of-use-early-stage-detection-key-with-cancer-blood-test-4454.html VolitionRx reports encouraging detection rates in colorectal cancer study https://www.proactiveinvestors.com/companies/news/120184/volitionrx-reports-encouraging-detection-rates-in-colorectal-cancer-study-120184.html Tue, 08 Dec 2015 13:09:00 -0500 https://www.proactiveinvestors.com/companies/news/120184/volitionrx-reports-encouraging-detection-rates-in-colorectal-cancer-study-120184.html VolitionRx CEO Cameron Reynolds presents at the Biotech Capital Conference https://www.proactiveinvestors.com/companies/news/304441/volitionrx-ceo-cameron-reynolds-presents-at-the-biotech-capital-conference-4441.html Fri, 04 Dec 2015 16:16:00 -0500 https://www.proactiveinvestors.com/companies/news/304441/volitionrx-ceo-cameron-reynolds-presents-at-the-biotech-capital-conference-4441.html VolitionRx to present at Los Angeles conference https://www.proactiveinvestors.com/companies/news/119842/volitionrx-to-present-at-los-angeles-conference-119842.html Mon, 30 Nov 2015 14:24:00 -0500 https://www.proactiveinvestors.com/companies/news/119842/volitionrx-to-present-at-los-angeles-conference-119842.html VolitionRx tests score highly in lung cancer detection study https://www.proactiveinvestors.com/companies/news/119439/volitionrx-tests-score-highly-in-lung-cancer-detection-study-119439.html Thu, 19 Nov 2015 21:25:00 -0500 https://www.proactiveinvestors.com/companies/news/119439/volitionrx-tests-score-highly-in-lung-cancer-detection-study-119439.html VolitionRx granted second US patent https://www.proactiveinvestors.com/companies/news/119317/volitionrx-granted-second-us-patent-119317.html Tue, 17 Nov 2015 15:44:00 -0500 https://www.proactiveinvestors.com/companies/news/119317/volitionrx-granted-second-us-patent-119317.html VolitionRx granted second patent for nucleosome cancer test https://www.proactiveinvestors.com/companies/news/119321/volitionrx-granted-second-patent-for-nucleosome-cancer-test-119321.html Tue, 17 Nov 2015 15:07:00 -0500 https://www.proactiveinvestors.com/companies/news/119321/volitionrx-granted-second-patent-for-nucleosome-cancer-test-119321.html VolitionRx chief to present at New York and London conferences https://www.proactiveinvestors.com/companies/news/119103/volitionrx-chief-to-present-at-new-york-and-london-conferences-119103.html Thu, 12 Nov 2015 13:36:00 -0500 https://www.proactiveinvestors.com/companies/news/119103/volitionrx-chief-to-present-at-new-york-and-london-conferences-119103.html VolitionRx expects final colorectal test results early next year https://www.proactiveinvestors.com/companies/news/117069/volitionrx-expects-final-colorectal-test-results-early-next-year-117069.html Wed, 04 Nov 2015 21:11:00 -0500 https://www.proactiveinvestors.com/companies/news/117069/volitionrx-expects-final-colorectal-test-results-early-next-year-117069.html VolitionRx: 95% detection in new pancreatic study https://www.proactiveinvestors.com/companies/news/116537/volitionrx-95-detection-in-new-pancreatic-study-116537.html Thu, 22 Oct 2015 12:23:00 -0400 https://www.proactiveinvestors.com/companies/news/116537/volitionrx-95-detection-in-new-pancreatic-study-116537.html VolitionRX developing "game changer" in pancreatic cancer diagnosis https://www.proactiveinvestors.com/companies/news/304262/volitionrx-developing-game-changer-in-pancreatic-cancer-diagnosis-4262.html Tue, 13 Oct 2015 06:41:00 -0400 https://www.proactiveinvestors.com/companies/news/304262/volitionrx-developing-game-changer-in-pancreatic-cancer-diagnosis-4262.html VolitionRx reveals “extremely encouraging” results of clinical study https://www.proactiveinvestors.com/companies/news/116117/volitionrx-reveals-extremely-encouraging-results-of-clinical-study-116117.html Mon, 12 Oct 2015 12:29:00 -0400 https://www.proactiveinvestors.com/companies/news/116117/volitionrx-reveals-extremely-encouraging-results-of-clinical-study-116117.html VolitionRX chief delighted with first CE Mark in Europe https://www.proactiveinvestors.com/companies/news/304173/volitionrx-chief-delighted-with-first-ce-mark-in-europe-4173.html Wed, 23 Sep 2015 10:22:00 -0400 https://www.proactiveinvestors.com/companies/news/304173/volitionrx-chief-delighted-with-first-ce-mark-in-europe-4173.html VolitionRx's first CE Mark paves way for European clinical sales https://www.proactiveinvestors.com/companies/news/111029/volitionrx-s-first-ce-mark-paves-way-for-european-clinical-sales-111029.html Tue, 22 Sep 2015 16:46:00 -0400 https://www.proactiveinvestors.com/companies/news/111029/volitionrx-s-first-ce-mark-paves-way-for-european-clinical-sales-111029.html VolitionRX chief: US patent crucial for long-term value https://www.proactiveinvestors.com/companies/news/304137/volitionrx-chief-us-patent-crucial-for-long-term-value-4137.html Tue, 15 Sep 2015 07:50:00 -0400 https://www.proactiveinvestors.com/companies/news/304137/volitionrx-chief-us-patent-crucial-for-long-term-value-4137.html VolitionRx hails first US patent as key milestone https://www.proactiveinvestors.com/companies/news/118502/volitionrx-hails-first-us-patent-as-key-milestone-118502.html Thu, 10 Sep 2015 13:57:00 -0400 https://www.proactiveinvestors.com/companies/news/118502/volitionrx-hails-first-us-patent-as-key-milestone-118502.html VolitionRx hails first US patent as key milestone. https://www.proactiveinvestors.com/companies/news/110686/volitionrx-hails-first-us-patent-as-key-milestone-110686.html Thu, 10 Sep 2015 11:37:00 -0400 https://www.proactiveinvestors.com/companies/news/110686/volitionrx-hails-first-us-patent-as-key-milestone-110686.html VolitionRX's NuQ test shines in Danish trial https://www.proactiveinvestors.com/companies/news/110654/volitionrx-s-nuq-test-shines-in-danish-trial-110654.html Wed, 09 Sep 2015 12:39:00 -0400 https://www.proactiveinvestors.com/companies/news/110654/volitionrx-s-nuq-test-shines-in-danish-trial-110654.html VolitionRx appoints David Kratochvil as CFO https://www.proactiveinvestors.com/companies/news/118498/volitionrx-appoints-david-kratochvil-as-cfo-118498.html Mon, 17 Aug 2015 15:00:00 -0400 https://www.proactiveinvestors.com/companies/news/118498/volitionrx-appoints-david-kratochvil-as-cfo-118498.html VolitionRx chief says key milestones are within reach https://www.proactiveinvestors.com/companies/news/304052/volitionrx-chief-says-key-milestones-are-within-reach-4052.html Wed, 12 Aug 2015 07:19:00 -0400 https://www.proactiveinvestors.com/companies/news/304052/volitionrx-chief-says-key-milestones-are-within-reach-4052.html UPDATE - VolitionRx set for a busy end to the year as it makes significant progress https://www.proactiveinvestors.com/companies/news/118493/update-volitionrx-set-for-a-busy-end-to-the-year-as-it-makes-significant-progress-118493.html Tue, 11 Aug 2015 20:00:00 -0400 https://www.proactiveinvestors.com/companies/news/118493/update-volitionrx-set-for-a-busy-end-to-the-year-as-it-makes-significant-progress-118493.html VolitionRx makes significant progress https://www.proactiveinvestors.com/companies/news/109863/volitionrx-makes-significant-progress-109863.html Tue, 11 Aug 2015 13:20:00 -0400 https://www.proactiveinvestors.com/companies/news/109863/volitionrx-makes-significant-progress-109863.html VolitionRx takes step towards US market with GSS tie-up https://www.proactiveinvestors.com/companies/news/109375/volitionrx-takes-step-towards-us-market-with-gss-tie-up-109375.html Mon, 27 Jul 2015 12:53:00 -0400 https://www.proactiveinvestors.com/companies/news/109375/volitionrx-takes-step-towards-us-market-with-gss-tie-up-109375.html VolitionRX seeks to revolutionise cancer diagnosis Share https://www.proactiveinvestors.com/companies/news/304355/volitionrx-seeks-to-revolutionise-cancer-diagnosis-share Tue, 07 Jul 2015 22:48:00 -0400 https://www.proactiveinvestors.com/companies/news/304355/volitionrx-seeks-to-revolutionise-cancer-diagnosis-share VolitionRX seeks to revolutionise cancer diagnosis https://www.proactiveinvestors.com/companies/news/303902/volitionrx-seeks-to-revolutionise-cancer-diagnosis-3902.html Wed, 01 Jul 2015 14:48:00 -0400 https://www.proactiveinvestors.com/companies/news/303902/volitionrx-seeks-to-revolutionise-cancer-diagnosis-3902.html